What Are Tirzepatide and Semaglutide?
Both are injectable medications originally developed for type 2 diabetes that demonstrated substantial weight loss benefits in clinical trials — large enough to earn FDA approval specifically for weight management.
Semaglutide is sold as Ozempic (diabetes) and Wegovy (weight loss). Rybelsus is the oral version, approved for diabetes only. Weekly subcutaneous injection at doses up to 2.4mg for weight management.
Tirzepatide is sold as Mounjaro (diabetes) and Zepbound (weight loss). Weekly subcutaneous injection at doses up to 15mg.
Both work by mimicking gut hormones that regulate appetite, slow gastric emptying, and affect how the brain processes hunger signals. The key difference is how many hormone receptors they target — and that difference translates directly into outcomes.
How They Work: GLP-1 vs Dual GIP/GLP-1
Semaglutide is a GLP-1 receptor agonist. GLP-1 (glucagon-like peptide-1) is released after meals and signals the brain to reduce appetite, slows digestion, and lowers post-meal blood glucose.
Tirzepatide is a dual GIP/GLP-1 receptor agonist. It activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). GIP is the other major gut hormone released after eating. Activating both pathways produces additive effects on appetite suppression and fat metabolism — which is why tirzepatide consistently outperforms semaglutide on weight loss endpoints.
In practical terms: both drugs make you less hungry and slow your eating. Tirzepatide does it through two mechanisms simultaneously, which is why the weight loss numbers are meaningfully larger.
Weight Loss Results: What the Data Shows
SURMOUNT-5 (the head-to-head trial)
The SURMOUNT-5 trial enrolled 751 adults with obesity without type 2 diabetes, randomized to tirzepatide (10mg or 15mg) or semaglutide 2.4mg for 72 weeks. Results:
| Tirzepatide (10–15mg) | Semaglutide (2.4mg) | |
|---|---|---|
| Average weight loss | 20.2% | 13.7% |
| ≥15% weight loss achieved | 78% of patients | 51% of patients |
| ≥25% weight loss achieved | 32% of patients | 16% of patients |
| Trial duration | 72 weeks | 72 weeks |
For context: the STEP 1 trial (semaglutide alone) found an average 14.9% body weight reduction over 68 weeks. The SURMOUNT-1 trial (tirzepatide alone) found up to 22.5% at the highest dose.
What this means for men specifically
Men typically lose slightly less weight than women on both drugs — roughly 15–18% on tirzepatide and 11–13% on semaglutide at therapeutic doses. Still clinically significant, and tirzepatide's advantage holds across sex subgroups.
The more relevant question for most guys isn't percentage of body weight — it's body composition. Both drugs cause some lean mass loss alongside fat loss. That's where training and protein intake become non-negotiable.
Side Effects Compared
Both share a class-level GI side effect profile. These are the ones to know:
Common (both drugs):
- Nausea — most pronounced in the first 4–12 weeks during dose escalation
- Diarrhea and constipation (often alternating early on)
- Decreased appetite (this is the mechanism, not just a side effect)
- Injection site reactions (minor, typically resolve)
Less common but important:
- Vomiting, particularly at higher doses
- Fatigue during initial titration
- GERD/heartburn (gastric emptying is slowed)
Serious (rare, same class risk):
- Pancreatitis (discontinue if severe abdominal pain)
- Thyroid C-cell tumor risk (contraindicated with personal/family history of medullary thyroid carcinoma — see FDA boxed warning)
- Gallbladder disease (elevated risk with rapid weight loss on either drug)
Tolerability in men: some clinical data and provider experience suggests men report GI side effects as somewhat less severe on tirzepatide vs semaglutide, though individual response varies. Slower titration — starting at lower doses and increasing gradually over 3–6 months — is the single most effective way to manage GI side effects on either drug.
Muscle loss: both cause some loss of lean mass. Studies show 25–35% of total weight lost is lean tissue on GLP-1 medications without intervention. Resistance training 3x+ per week and protein at 0.7–1g per pound of body weight significantly reduce this — not optional if you care about body composition outcomes.
See also: Can Tirzepatide Cause Body Aches?
Cost, Coverage and Availability
Brand-name pricing (without insurance)
| Tirzepatide (Mounjaro/Zepbound) | Semaglutide (Wegovy/Ozempic) | |
|---|---|---|
| Monthly cost | $900–$1,300+ | $900–$1,200+ |
| Insurance coverage | Variable; Zepbound (weight loss) often excluded | Variable; Wegovy often excluded for weight loss |
| Injection frequency | Weekly | Weekly |
Compounded GLP-1 medications
Compounded tirzepatide and semaglutide — produced by 503B compounding pharmacies — have been widely available at significantly lower cost:
- Compounded semaglutide: $150–$400/month depending on dose and provider
- Compounded tirzepatide: $200–$500/month
Important: The FDA has attempted to restrict compounded GLP-1s as brand-name supplies normalized. Availability varies by state and evolves frequently. A licensed prescriber can advise on what's currently accessible.
Through online men's health clinics
Several online clinics offer GLP-1 programs that include physician evaluation, lab work, medication (compounded or brand), and ongoing monitoring. Monthly all-in costs typically run $200–$500. These are the most accessible path for most men, particularly those without insurance coverage for weight management.
Which Is the Better Choice for Men?
Choose tirzepatide if:
- Maximum weight loss is the priority and you can access it at reasonable cost
- You've tried semaglutide and didn't get the results you wanted
- Body composition is a major goal (slightly better muscle preservation data)
- Cost difference is manageable through compounding or coverage
Choose semaglutide if:
- Access or cost makes tirzepatide impractical right now
- You're looking for the longer-established safety record
- Your provider has more experience managing semaglutide protocols
- You're in a state where compounded semaglutide is currently available and affordable
For men combining GLP-1s with hormone optimization: If you're on TRT or HRT alongside a GLP-1, the combination can produce strong body composition results — testosterone helps preserve muscle during the caloric deficit GLP-1s create. A provider who understands both is worth seeking out.
Where to Find a Provider Who Prescribes GLP-1 Medications
Not all men's health clinics prescribe GLP-1 medications, and not all weight loss clinics understand male-specific considerations — testosterone interaction, body composition goals, muscle preservation. Finding a provider who covers both is worth the search.
Online options: Several telehealth platforms specialize in GLP-1 prescriptions with physician oversight, labs, and medication delivery. Compare online weight loss and GLP-1 providers → AHF lists current options with pricing, included services, and availability by state.
In-person options: For men who want hands-on monitoring or who are combining GLP-1s with TRT, a local men's health or weight management clinic is worth the in-person visit. Find GLP-1 clinics in your state or browse AHF's full clinic directory.
Also see: Weight Management Treatments Overview
Frequently Asked Questions
Is tirzepatide or semaglutide better for weight loss?
Tirzepatide produces greater average weight loss — 20.2% vs 13.7% for semaglutide at 72 weeks in the SURMOUNT-5 trial. Both are effective; tirzepatide's dual GIP/GLP-1 mechanism gives it a meaningful edge in total weight reduction.
Which has fewer side effects — tirzepatide or semaglutide?
Both share GI side effects — nausea, diarrhea, constipation — that are most pronounced during dose escalation and typically improve after 4–8 weeks. Some data suggests tirzepatide is slightly better tolerated in men, but individual response varies. Side effects are dose-dependent; slower titration reduces GI burden on both.
Can tirzepatide or semaglutide cause muscle loss?
Both medications can cause some loss of lean mass alongside fat loss — typically 25–35% of total weight lost is lean tissue. Resistance training at least 3x per week and adequate protein intake (0.7–1g per pound of body weight) significantly reduce muscle loss on either drug.
How much do tirzepatide and semaglutide cost?
Brand-name Mounjaro (tirzepatide) and Wegovy/Ozempic (semaglutide) run $900–$1,300+/month without insurance. Compounded versions are significantly cheaper — $200–$500/month depending on the provider and dose. Online men's health clinics typically offer GLP-1 programs including medication, labs, and physician oversight.
This article is for informational purposes only and does not constitute medical advice. Consult a licensed physician before starting any GLP-1 medication.